Literature DB >> 12181730

A successful resection and long-term survival of a patient with intrahepatic recurrences of combined hepatocellular-cholangiocarcinoma: report of a case.

Hidetoshi Eguchi1, Hiroaki Nagano, Masato Sakon, Atsushi Miyamoto, Motoi Kondo, Isao Arai, Osakuni Morimoto, Keizo Dono, Koji Umeshita, Shoji Nakamori, Kenichi Wakasa, Morito Monden.   

Abstract

Because of the low incidence rate of combined hepatocellular-cholangiocarcinoma (combined HCC-CC), the clinicopathological features of a recurrent tumor of this disease remain to be elucidated. We describe a 47-year-old Japanese woman with a 5-cm diameter mass lesion in the liver. A hepatectomy and dissection of the local lymph nodes were performed and a histological examination of the resected specimen showed combined HCC-CC. After a follow-up of 15 months, intrahepatic recurrence was observed, and a hepatectomy was performed again followed by hepatic arterial infusion chemotherapy. A histological examination revealed that the recurrent tumors consisted of only cholangioacarcinoma. A disease-free survival was obtained for about 7 years after the recurrence. To improve the poor prognosis of combined HCC-CC, clinicopathological features of this disease and the therapy selection for recurrent tumors should be discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12181730     DOI: 10.1007/s005950200140

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  3 in total

1.  Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review.

Authors:  Ming Chi; Kaidi Mikhitarian; Chanjuan Shi; Laura W Goff
Journal:  Gastrointest Cancer Res       Date:  2012-11

2.  Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.

Authors:  Di Tang; Hiroaki Nagano; Masato Nakamura; Hiroshi Wada; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Koji Umeshita; Keizo Dono; Morito Monden
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

Review 3.  Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.

Authors:  An-Qiang Wang; Yong-Chang Zheng; Juan Du; Cheng-Pei Zhu; Han-Chun Huang; Shan-Shan Wang; Liang-Cai Wu; Xue-Shuai Wan; Hao-Hai Zhang; Ruo-Yu Miao; Xin-Ting Sang; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.